Chlorothiazide sodium
Active substance: chlorothiazide
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · CHLOROTHIAZIDE SODIUM 500 mg/18mL
United StatesActive
Marketing holder: Gland Pharma Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CHLOROTHIAZIDE SODIUM · 500 mg/18mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-1304-7ddc-917b-3c51713f2090,01a1208e-bba2-73d0-94ef-9159d8e5e5eb,01a12090-425a-7085-ab70-ba9ea4026024,01a12096-e8b1-75b1-b444-dfcd20057f88,01a1209d-5dae-70a9-9476-d8022f120479;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68083-614
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 68083-614 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68083-614 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68083-614 · Verified 2026-10-09 · open in source